We are a San Francisco Bay Area-based research stage biopharmaceutical company aiming to discover, develop & commercialize innovative therapeutics for the treatment of rare & age-related diseases. We are developing compounds to modulate molecular pathways that address the underlying causes of disease initiation and progression, such as oxidative, cellular and environmental stress. Our lead compounds are novel & highly selectiv...
We are a San Francisco Bay Area-based research stage biopharmaceutical company aiming to discover, develop & commercialize innovative therapeutics for the treatment of rare & age-related diseases. We are developing compounds to modulate molecular pathways that address the underlying causes of disease initiation and progression, such as oxidative, cellular and environmental stress. Our lead compounds are novel & highly selective therapeutics that potently inhibit the mTORC1 pathway. Genetic mutations, aging result in abnormal activation of mTORC1; normalization of its aberrant activity.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.